NCT03672006View on ClinicalTrials.gov

t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions
Central Venous Catheter ThrombosisCentral Venous Catheter Associated Bloodstream Infection
Interventions
BIOLOGICAL

alteplase (recombinant t-PA)

Medication administered to dwell in central venous catheter

DRUG

Heparin

Medication administered to dwell in central venous catheter

Trial Locations (1)

53201

Children's Hospital of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT03672006 - t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection | Biotech Hunter | Biotech Hunter